MOC-D-Valine
MOC-D-Valine Basic information
- Product Name:
- MOC-D-Valine
- Synonyms:
-
- MOC-D-Valine
- MOC-D-VAL-OH
- (2R)-2-(methoxycarbonylamino)-3-methylbutanoic acid
- (R)-2-(Methoxycarbonylamino)-3-methylbutanoic acid
- (R)-2-((Methoxycarbonyl)aMino)-4-Methylbutanoic acid
- Methoxycarbonyl-D-Valine
- N-METHOXYCARBONYL-D-VALINE
- (R)-(+)-N-(Methoxycarbonyl)valine
- CAS:
- 171567-86-5
- MF:
- C7H13NO4
- MW:
- 175.18
- Mol File:
- 171567-86-5.mol
MOC-D-Valine Chemical Properties
- Boiling point:
- 315.9±25.0 °C(Predicted)
- Density
- 1.154±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- pka
- 4.44±0.10(Predicted)
- Appearance
- White to off-white Solid
MOC-D-Valine Usage And Synthesis
Uses
(R)-2-((Methoxycarbonyl)amino)-3-methylbutanoic Acid is used in the synthetic preparation of dipeptide-capped bis-phenylimidazole derivatives as hepatitis C virus NS5A replication complex inhibitors.
Synthesis
640-68-6
79-22-1
171567-86-5
The general procedure for the synthesis of (R)-2-(methoxycarbonylamino)-3-methylbutanoic acid from D-valine and methyl chloroformate was as follows: sodium carbonate (276 mg, 2.6 mmol) was added to an aqueous sodium hydroxide solution (5 mL, 1 M, 5 mmol) containing D-valine (586 mg, 5.00 mmol), and the resultant solution was subsequently cooled in an ice water bath. . Methyl chloroformate (0.420 mL, 5.40 mmol) was slowly added dropwise with stirring. After completion of the dropwise addition, the ice water bath was removed and the reaction mixture was continued to be stirred at room temperature for 3.25 hours. After completion of the reaction, the reaction mixture was washed with ether (3 x 9 mL). The aqueous phase was again cooled in an ice water bath and acidified to pH 1-2 with concentrated hydrochloric acid and then extracted with dichloromethane (3 x 9 mL). The organic phases were combined, dried with anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to afford the target product (R)-2-(methoxycarbonylamino)-3-methylbutyric acid (760 mg, 87% yield) as a white solid. The product was characterized by 1H NMR (DMSO-d6, δ= 2.5 ppm, 300 MHz): 12.54 (s, 1H), 7.32 (d, 1H), 3.84 (t, 1H), 3.54 (s, 3H), 2.03 (m, 1H), 0.87 (d, 6H).
References
[1] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 3, p. 255 - 258
[2] European Journal of Medicinal Chemistry, 2017, vol. 125, p. 87 - 100
[3] Patent: KR2017/31307, 2017, A. Location in patent: Paragraph 0161-0163
[4] RSC Advances, 2018, vol. 8, # 55, p. 31803 - 31821
MOC-D-ValineSupplier
- Tel
- 0757-86329057 18934348241
- sales4.gd@hwrkchemical.com
- Tel
- 021-021-58432009 400-005-6266
- sales8178@energy-chemical.com
- Tel
- 400-6009262 16621234537
- chenyj@titansci.com
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
- Tel
- 0755-0755-66853366 13670046396
- sales@chem-strong.com
MOC-D-Valine(171567-86-5)Related Product Information
- Moc-Leu-OH
- (2R)-1-methoxycarbonylpyrrolidine-2-carboxylic acid
- Moc-Ile-OH
- Moc-Val-Val-OH
- 1,2-Pyrrolidinedicarboxylicacid,1-methylester,(2S)-(9CI)
- Methoxycarbonyl-L-tert-leucine
- Benzeneacetic acid, a-[(Methoxycarbonyl)aMino]-, (S)-
- (S)-2-((Methoxycarbonyl)aMino)-3-Methylbutanoic acid
- (R)-2-(methoxycarbonylamino)-2-phenylacetic acid